一项人口药理动力学研究,评估所有年龄组对多克索鲁比辛的暴露
Ma Ida Mohmaed Ali1,2, A Laura Nijstad3, René J Boosman4,5
1Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. m.mohmaed@nki.nl.
Clinical pharmacokinetics
|November 16, 2024
概括
年龄不会显著改变多克索鲁比辛的药理动力学,支持当前适用于儿科和成人患者的剂量指南. 不同年龄段的剂量调整在临床上并不必要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药理动力学 药理动力学
- 在瘤学瘤学.
背景情况:
- 年龄对多克索鲁比药理学的影响尚未完全理解,特别是在非常年轻和老年患者中.
- 需要澄清与年龄相关的药理动力学差异,以获得最佳的多克索鲁比治疗.
研究的目的:
- 为广泛的年龄段开发多克索鲁比的种群药动力学模型.
- 调查早期发育和衰老对多克索鲁比药理学的影响.
主要方法:
- 采用了具有全米缩放的三隔间模型.
- 结合成熟和Emax函数来建模与年龄相关的清除和分布量的变化.
- 进行模拟以评估观察到的药理动力学变化的临床相关性.
主要成果:
- 该研究包括168名年龄在0.11到90岁之间的患者,555个多克索鲁比样本.
- 观察到中央 (V1) 和外围 (V2) 分布体的与年龄相关的变化,在成熟过程中随着年龄的增加而增加.
- 随着年龄的增长,第三部分 (V3) 的分布量有所减少,但整体多克索鲁比辛暴露在年龄组之间没有临床显著的差异.
结论:
- 种群药动力学建模表明,年龄主要影响多克索鲁比的分布量.
- 这些与年龄相关的药物动力学变化没有临床意义.
- 目前的多克索鲁比剂量策略,包括基于体重的婴儿和基于BSA的其他婴儿,得到支持.
相关概念视频
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
49
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
49
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Drug Concentrations: Measurements
332
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
332
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
87
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
87


